[EN] INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X<br/>[FR] INHIBITION DE LA PEPTIDASE 9X SPÉCIFIQUE DE L'UBIQUITINE
申请人:FORMA THERAPEUTICS INC
公开号:WO2020139916A1
公开(公告)日:2020-07-02
The disclosure provides novel chemical compounds useful as inhibitors of ubiquitin specific peptidase 9X (USP9X). USP9X inhibiting compounds are useful in the treatment of disease and disorders associated with modulation of USP9X, such as cancer.
该披露提供了一种新颖的化合物,可用作泛素特异性
蛋白酶9X(U
SP9X)的
抑制剂。抑制U
SP9X的化合物在治疗与调节U
SP9X相关的疾病和紊乱,如癌症,方面是有用的。